Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies

Figure 4

Forest plot of the progression-free survival (PFS) of GC patients with T2DM after exposure to metformin (p = 0.008).